Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ann Cathrine Dalgård Dunvald"'
Autor:
Anne-Maj Knudsen, Ann-Cathrine Dalgård Dunvald, Stine Hangaard, Ole Hejlesen, Thomas Kronborg
Publikováno v:
JMIR Research Protocols, Vol 13, p e58296 (2024)
BackgroundCollaborative care interventions have been proposed as a promising strategy to support patients with multimorbidity. Despite this, the effectiveness of collaborative care interventions requires further evaluation. Existing systematic review
Externí odkaz:
https://doaj.org/article/c5f99dc01a8d4c4a8eae7ba09acfe1dc
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 6, Pp 937-945 (2023)
Abstract Diverse representation in clinical trials is crucial to understand the efficacy and safety of drugs in minority groups. This review aims to (1) describe research participants' sex, racial, and ethnic diversity in clinical drug trials and (2)
Externí odkaz:
https://doaj.org/article/c57b61a319844f4eb663976d2c15f323
Autor:
Ann‐Cathrine Dalgård Dunvald, Ditte Bork Iversen, Andreas Ludvig Ohm Svendsen, Katrine Agergaard, Ida Berglund Kuhlmann, Christina Mortensen, Nanna Elman Andersen, Erkka Järvinen, Tore Bjerregaard Stage
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 8, Pp 1856-1866 (2022)
Abstract Pharmacokinetics is the cornerstone of understanding drug absorption, distribution, metabolism, and elimination. It is also the key to describing variability in drug response caused by drug‐drug interactions (DDIs), pharmacogenetics, impai
Externí odkaz:
https://doaj.org/article/7a36e3f5377e46e1a3936664ac9259f5
Autor:
Ditte B. Iversen, Ann‐Cathrine Dalgård Dunvald, Daniel M. Jespersen, Flemming Nielsen, Kim Brøsen, Per Damkier, Helen S. Hammer, Oliver Pötz, Erkka Järvinen, Tore B. Stage
Publikováno v:
Clinical Pharmacology & Therapeutics.
Autor:
Erkka Järvinen, Ann‐Cathrine Dalgård Dunvald, Martin Thomsen Ernst, Helen S. Hammer, Oliver Pötz, Anton Pottegård, Tore B. Stage
Publikováno v:
British Journal of Clinical Pharmacology.
Autor:
Ann‐Cathrine Dalgård Dunvald, Flemming Nielsen, Dorte Aalund Olsen, Martin Thomsen Ernst, Louise Donnelly, Enrique Soto‐Pedre, Maja Refshauge Kristiansen, Jens Steen Nielsen, Frederik Persson, Kurt Højlund, Jonna Skov Madsen, Jens Søndergaard, Ewan Pearson, Anton Pottegård, Tore Bjerregaard Stage
Publikováno v:
British Journal of Clinical Pharmacology.
Publikováno v:
Clinical pharmacology and therapeutics. 112(2)
Inflammation is a possible cause of variability in drug response and toxicity due to altered regulation in drug-metabolizing enzymes and transporters (DMETs) in humans. Here, we evaluate the clinical and in vitro evidence on inflammation-mediated mod
Autor:
Lars Christian Lund, Jesper Hallas, Mette Marie Hougaard Christensen, Daniel Pilsgaard Henriksen, Ann-Cathrine Dalgård Dunvald
Publikováno v:
Dunvald, A-C, Henriksen, D P, Hallas, J, Christensen, M M & Lund, L C 2020, ' Selective serotonin reuptake inhibitors and the risk of restless legs syndrome : a symmetry analysis ', European Journal of Clinical Pharmacology, vol. 76, no. 5, pp. 719-722 . https://doi.org/10.1007/s00228-020-02847-7
Purpose Largely based on case series, several drugs have been implicated in drug-induced restless legs syndrome (RLS)including selective serotonin reuptake inhibitors (SSRI). We aimed to assess the association between initiation of SSRIs andRLS in a